cGMP-Dependent Protein Kinase Contributes to Hydrogen Sulfide-Stimulated Vasorelaxation

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Bucci, Mariarosaria ^a   Papapetropoulos, Andreas ^b,c   Vellecco, Valentina ^a   Zhou, Zongmin ^d   Zaid, Altaany ^e   Giannogonas, Panagiotis ^c   Cantalupo, Anna ^a   Dhayade, Sandeep ^f   Karalis, Katia P ^c   Wang, Rui ^e   Feil, Robert ^f   Cirino, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PATRAS   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e LAKEHEAD UNIVERSITY   (Canada)

^f UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; CYSTATHIONINE GAMMA LYASE; CYSTEINE; ENZYME INHIBITOR; GLIBENCLAMIDE; HYDROGEN SULFIDE; PHENYLEPHRINE; PHOSPHOPROTEIN; SILDENAFIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME IMMUNOASSAY; FEMALE; GENE DELETION; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA; CELLS, CULTURED; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; ENDOTHELIUM, VASCULAR; FEMALE; HYDROGEN SULFIDE; MALE; MICE; MICE, KNOCKOUT; PHOSPHODIESTERASE 5 INHIBITORS; RATS; RATS, WISTAR; VASODILATION;

ANIMALIA; MAMMALIA; MUS;

EID: 84871703163     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053319     Document Type: Article

References (48)

1. Mustafa A, Gadalla M, Snyder S, (2009) Signaling by Gasotransmitters. Sci Signal 2: re2.
2. Wang R, (2002) Two's company, three's a crowd - Can H2S be the third endogenous gaseous transmitter? FASEB J 16: 1792-1798.
3. Sessa W, (2004) eNOS at a glance. J Cell Sci 117: 2427-2429.
4. Motterlini R, Otterbein L, (2010) The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9: 728-743.
5. Szabó C, (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935.
6. Li L, Hsu A, Moore P, (2009) Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation- a tale of three gases!. Pharmacol Ther 123: 386-400.
7. Whiteman M, Winyard P, (2011) Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev Clin Pharmacol 4: 13-32.
8. Kimura H, (2010) Hydrogen sulfide: from brain to gut. Antioxid Redox Signal 12: 1111-1123.
9. Li L, Rose P, Moore P, (2011) Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 51.
10. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H, (2009) Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 146: 623-626.
11. Wang R, (2009) Hydrogen sulfide: a new EDRF. Kidney Int 76: 700-704.
12. Calvert J, Coetzee W, Lefer D, (2010) Novel insights into hydrogen sulfide-mediated cytoprotection. Antioxid Redox Signal 12: 1203-1217.
13. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, et al. (2009) Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A 106: 21972-21977.
14. Lavu M, Bhushan S, Lefer D, (2011) Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential. Clin Sci (Lond) 120: 219-229.
15. Liu Y, Yan C, Bian J, (2011) Hydrogen sulfide: a novel signaling molecule in the vascular system. J Cardiovasc Pharmacol Jan 28. [Epub ahead of print].
16. Zhao W, Ndisang J, Wang R, (2003) Modulation of endogenous production of H2S in rat tissues. Can J Physiol Pharmacol 81: 848-853.
17. Yan H, Du J, C T, (2004) The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004 313: 22-27.
18. Roy A, Khan A, Islam M, Prieto M, Majid D, (2011) Interdependency of Cystathione γ-Lyase and Cystathione β-Synthase in Hydrogen Sulfide-Induced Blood Pressure Regulation in Rats. Am J Hypertens doi: 10.1038/ajh.2011.149.
19. Yang G, Wu L, Jiang B, Yang W, Qi J, et al. (2008) H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590.
20. Li L, Whiteman M, Guan Y, Neo K, Cheng Y, et al. (2008) Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 117: 2351-2360.
21. Zhao W, Zhang J, Lu Y, Wang R, (2001) The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 20: 6008-6016.
22. Wang R, (2011) Signaling pathways for the vascular effects of hydrogen sulfide. Curr Opin Nepherol Hypertens 20: 107-112.
23. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, et al. (2010) Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30: 1998-2004.
24. Ibarra-Alvarado C, Galle J, Melichar V, Mameghani A, Schmidt H, (2002) Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling. Mol Pharmacol 61: 312-319.
25. Gambaryan S, Butt E, Kobsar A, Geiger J, Rukoyatkina N, et al. (2012) Br J Pharmacol 167: 826-38.
26. Mustafa A, Sikka G, Gazi S, Steppan J, Jung S, et al. (2011) Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels. Circ Res 109: 1259-1268.
27. Jiang B, Tang G, Cao K, Wu L, Wang R, (2010) Molecular mechanism for H(2)S-induced activation of K(ATP) channels. Antioxid Redox Signal 12: 1167-1178.
28. Cheng Y, Ndisang J, Tang G, Cao K, Wang R, (2004) Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 287: H2316-2323.
29. Cheang W, Wong W, Shen B, Lau C, Tian X, et al. (2010) 4-aminopyridine-sensitive K+ channels contributes to NaHS-induced membrane hyperpolarization and relaxation in the rat coronary artery. Vasc Pharmacol 53: 94-98.
30. Kubo S, Doe I, Kurokawa Y, Nishikawa H, Kawabata A, (2007) Direct inhibition of endothelial nitric oxide synthase by hydrogen sulfide: contribution to dual modulation of vascular tension. Toxicology 232: 138-146.
31. Teixeira C, Priviero F, Webb R, (2006) Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta. J Pharmacol Exp Ther 316: 654-661.
32. Hofmann F, (2004) The biology of cyclic GMP-dependent protein kinases. J Biol Chem 280: 1-4.
33. Hu L, Li Y, Neo K, Yong Q, Lee S, et al. (2011) Hydrogen sulfide regulates Na+/H+ exchanger activity via stimulation of phosphoinositide 3-kinase/Akt and protein kinase G pathways. J Pharmacol Exp Ther 339: 726-735.
34. Dostmann WRG, Taylor MS, Nickl CK, Brayden JE, Frank R, et al. (2000) Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. Proc Natl Acad Sci U S A 97: 14772-14777.
35. Dhaese I, Lefebvre R, (2009) Myosin light chain phosphatase activation is involved in the hydrogen sulfide-induced relaxation in mouse gastric fundus. Eur J Pharmacol 606: 180-186.
36. Zhao W, Wang R, (2002) H2S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol 283.
37. Brancaleone V, Roviezzo F, Vellecco V, De Gruttola L, Bucci M, et al. (2008) Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol 155: 673-680.
38. Zhao Y, Brandish P, DiValentin M, Schelvis J, Babcock G, et al. (2000) Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 39: 10848-10854.
39. Zhou Z, von Wantoch Rekowski M, Coletta C, Szabo C, Bucci M, et al. (2012) Thioglycine and l-thiovaline: Biologically active H2S-donors. Bioorganic & Medicinal Chemistry 20: 2675-2678.
40. Costa ADT, Garlid KD, West IC, Lincoln TM, Downey JM, et al. (2005) Protein Kinase G Transmits the Cardioprotective Signal From Cytosol to Mitochondria. Circulation Research 97: 329-336.
41. Cuong DV, Kim N, Youm JB, Joo H, Warda M, et al. (2006) Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts. American Journal of Physiology- Heart and Circulatory Physiology 290: H1808-H1817.
42. Han J, Kim N, Joo H, Kim E, Earm Y, (2002) ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 283: H1545-1554.
43. Chai Y, Zhang D-M, Lin Y-F, (2011) Activation of cGMP-Dependent Protein Kinase Stimulates Cardiac ATP-Sensitive Potassium Channels via a ROS/Calmodulin/CaMKII Signaling Cascade. PLoS ONE 6: e18191.
44. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, et al. (2011) Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci U S A 108: 13829-13834.
45. Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Módis K, et al. (2012) Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proceedings of the National Academy of Sciences 109: 9161-9166.
46. Wegener J, Nawrath H, Wolfsgrube rW, Kühbandner S, Werner C, et al. (2002) cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium. Circ Res 90: 18-20.
47. Valtcheva N, Nestorov P, Beck A, Russwurm M, Hillenbrand M, et al. (2009) The Commonly Used cGMP-dependent Protein Kinase Type I (cGKI) Inhibitor Rp-8-Br-PET-cGMPS Can Activate cGKI in Vitro and in Intact Cells. Journal of Biological Chemistry 284: 556-562.
48. Papapetropoulos A, Marczin N, Snead M, Cheng C, Milici A, et al. (1994) Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension 23: 476-484.